Markets:

Overview

News

Currencies

International

Treasuries

AtriCure, Inc. - Common Stock (NQ:ATRC)

37.94 -0.47 (-1.22%)

Streaming Delayed Price Updated: 1:59 PM EST, Jan 28, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AtriCure, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

AtriCure: Q2 Earnings Insights ↗

August 02, 2022

AtriCure (NASDAQ:ATRC) reported its Q2 earnings results on Tuesday, August 2, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...

Via Benzinga

AtriCure Reports Second Quarter 2022 Financial Results

August 02, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate at Upcoming Investor Conferences

July 20, 2022

From AtriCure, Inc.

Via Business Wire

5 Analysts Have This to Say About AtriCure ↗

July 18, 2022

Over the past 3 months, 5 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

AtriCure to Announce Second Quarter 2022 Financial Results

July 12, 2022

From AtriCure, Inc.

Via Business Wire

Analyst Ratings for AtriCure ↗

June 28, 2022

Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

AtriCure Announces the First Patient Treated in the HEAL-IST Clinical Trial

June 07, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure Announces the Appointment of Deborah Yount as Chief Human Resources Officer

June 01, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure's Q1 EPS Miss Estimates, Needham Lowers Price Target ↗

May 04, 2022

Needham lowered AtriCure Inc's (NASDAQ: ATRC) price target to $67 from $79 due to peer multiple compression, with the Buy rating unchanged.

Via Benzinga

4 Analysts Have This to Say About AtriCure ↗

May 04, 2022

Over the past 3 months, 4 analysts have published their opinion on AtriCure (NASDAQ:ATRC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

AtriCure: Q1 Earnings Insights ↗

May 03, 2022

AtriCure (NASDAQ:ATRC) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings by...

Via Benzinga

AtriCure Reports First Quarter 2022 Financial Results

May 03, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure Launches EnCompass® Clamp, a part of Isolator Synergy™ Ablation System

April 12, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce First Quarter 2022 Financial Results

April 11, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Deeper Losses In Q4 Despite 27% Jump In Sales, Issues FY22 Guidance ↗

February 16, 2022

AtriCure Inc (NASDAQ: ATRC) reported Q4

Via Benzinga

Recap: AtriCure Q4 Earnings ↗

February 15, 2022

AtriCure (NASDAQ:ATRC) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:01 PM. Here's what investors need to know about the announcement. Earnings AtriCure missed estimated earnings...

Via Benzinga

AtriCure Reports Fourth Quarter 2021 and Full Year 2021 Financial Results

February 15, 2022

From AtriCure, Inc.

Via Business Wire

The Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics ↗

February 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus ImmunityBio Says Cancer Combo Therapy Produces Positive Results In Late-Stage...

Via Benzinga

Earnings Scheduled For February 15, 2022 ↗

February 15, 2022

Companies Reporting Before The Bell • FirstService (NASDAQ:FSV) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.07 billion.

Via Benzinga

A Preview Of AtriCure's Earnings ↗

February 14, 2022

AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2022-02-15. Here's what investors need to know before the announcement. Analysts estimate that AtriCure will...

Via Benzinga

The Week Ahead In Biotech (Feb. 13-19): Agios FDA Meeting, Avenue Adcom, Earnings And More ↗

February 13, 2022

Biotech stocks moved back and forth amid some volatility before finishing the week ending Feb. 11 modestly lower, reversing the gains from the previous week. Earnings news...

Via Benzinga

AtriCure Publishes Inaugural ESG Report

February 08, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

February 01, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Announce Fourth Quarter and Full Year 2021 Financial Results

January 25, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2021, Provides Financial Outlook for 2022

January 10, 2022

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in the 40th Annual J.P. Morgan Healthcare Conference

December 20, 2021

From AtriCure, Inc.

Via Business Wire

AtriCure to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference

November 12, 2021

From AtriCure, Inc.

Via Business Wire

AtriCure, inc (ATRC) Q3 2021 Earnings Call Transcript ↗

November 04, 2021

ATRC earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

AtriCure Reports Third Quarter 2021 Financial Results

November 03, 2021

From AtriCure, Inc.

Via Business Wire

The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering ↗

November 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...

Via Benzinga

Topics Retirement

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.